Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 288

1.

Primary predictors of survival outcomes for HER2-positive advanced breast cancer patients initiating ado-trastuzumab emtansine.

Hopkins AM, Rowland A, Logan JM, Sorich MJ.

Breast. 2019 May 11;46:90-94. doi: 10.1016/j.breast.2019.05.011. [Epub ahead of print]

PMID:
31170589
2.

Identification of the caffeine to trimethyluric acid ratio as a dietary biomarker to characterise variability in cytochrome P450 3A activity.

van Dyk M, Miners JO, Marshall JC, Wood LS, Hopkins A, Sorich MJ, Rowland A.

Eur J Clin Pharmacol. 2019 May 23. doi: 10.1007/s00228-019-02682-5. [Epub ahead of print]

PMID:
31123759
3.

Fracture of allograft interbody spacer resulting in post-operative radiculopathy: A case report.

Kyle A, Rowland A, Stirton J, Elgafy H.

World J Orthop. 2019 Apr 18;10(4):206-211. doi: 10.5312/wjo.v10.i4.206. eCollection 2019 Apr 18.

4.

Evaluation of the lung immune prognostic index for prediction of survival and response in patients treated with atezolizumab for non-small cell lung cancer: pooled analysis of clinical trials.

Sorich MJ, Rowland A, Karapetis CS, Hopkins AM.

J Thorac Oncol. 2019 Apr 15. pii: S1556-0864(19)30285-0. doi: 10.1016/j.jtho.2019.04.006. [Epub ahead of print]

PMID:
30999110
5.

Knee locked in flexion: incarcerated semitendinosus tendon around a proximal tibial osteochondroma.

Andrews K, Rowland A, Tank J.

J Surg Case Rep. 2019 Feb 8;2019(2):rjy346. doi: 10.1093/jscr/rjy346. eCollection 2019 Feb.

6.

Effect of early adverse events on response and survival outcomes of advanced melanoma patients treated with vemurafenib or vemurafenib plus cobimetinib: A pooled analysis of clinical trial data.

Hopkins AM, Van Dyk M, Rowland A, Sorich MJ.

Pigment Cell Melanoma Res. 2019 Feb 13. doi: 10.1111/pcmr.12773. [Epub ahead of print]

PMID:
30758912
7.

The UDP-Glycosyltransferase (UGT) Superfamily: New Members, New Functions, and Novel Paradigms.

Meech R, Hu DG, McKinnon RA, Mubarokah SN, Haines AZ, Nair PC, Rowland A, Mackenzie PI.

Physiol Rev. 2019 Apr 1;99(2):1153-1222. doi: 10.1152/physrev.00058.2017. Review.

PMID:
30724669
8.

A retrospective cohort study of racing performance in Quarter Horses undergoing prosthetic laryngoplasty for treatment of recurrent laryngeal neuropathy.

Krueger CR, Lewis RD, McIlwraith CW, Major MD, Brakenhoff JE, Hand DR, Rowland AL, Hess AM, Johnson SW, Hackett ES.

J Am Vet Med Assoc. 2019 Feb 15;254(4):496-500. doi: 10.2460/javma.254.4.496.

PMID:
30714865
9.

Use of Physiologically Based Pharmacokinetic Modeling to Identify Physiological and Molecular Characteristics Driving Variability in Axitinib Exposure: A Fresh Approach to Precision Dosing in Oncology.

Sorich MJ, Mutlib F, van Dyk M, Hopkins AM, Polasek TM, Marshall JC, Rodrigues AD, Rowland A.

J Clin Pharmacol. 2019 Jun;59(6):872-879. doi: 10.1002/jcph.1377. Epub 2019 Jan 11.

PMID:
30633368
11.

Toward Dynamic Prescribing Information: Codevelopment of Companion Model-Informed Precision Dosing Tools in Drug Development.

Polasek TM, Rayner CR, Peck RW, Rowland A, Kimko H, Rostami-Hodjegan A.

Clin Pharmacol Drug Dev. 2019 May;8(4):418-425. doi: 10.1002/cpdd.638. Epub 2018 Nov 30.

PMID:
30500115
12.

Students Who Fail to Achieve Predefined Research Goals May Still Experience Many Positive Outcomes as a Result of CURE Participation.

Gin LE, Rowland AA, Steinwand B, Bruno J, Corwin LA.

CBE Life Sci Educ. 2018 Dec;17(4):ar57. doi: 10.1187/cbe.18-03-0036.

PMID:
30417757
13.

In vitro MSC function is related to clinical reaction in vivo.

Rowland AL, Xu JJ, Joswig AJ, Gregory CA, Antczak DF, Cummings KJ, Watts AE.

Stem Cell Res Ther. 2018 Nov 8;9(1):295. doi: 10.1186/s13287-018-1037-4.

14.

Plasma extracellular nanovesicle (exosome)-derived biomarkers for drug metabolism pathways: a novel approach to characterize variability in drug exposure.

Rowland A, Ruanglertboon W, van Dyk M, Wijayakumara D, Wood LS, Meech R, Mackenzie PI, Rodrigues AD, Marshall JC, Sorich MJ.

Br J Clin Pharmacol. 2019 Jan;85(1):216-226. doi: 10.1111/bcp.13793. Epub 2018 Nov 16.

PMID:
30340248
15.

Bone Marrow Aspiration Does Not Induce a Measurable Pain Response Compared to Sham Procedure.

Rowland AL, Navas de Solis C, Lepiz MA, Cummings KJ, Watts AE.

Front Vet Sci. 2018 Oct 1;5:233. doi: 10.3389/fvets.2018.00233. eCollection 2018.

16.

Risk Factors for Severe Diarrhea with an Afatinib Treatment of Non-Small Cell Lung Cancer: A Pooled Analysis of Clinical Trials.

Hopkins AM, Nguyen AM, Karapetis CS, Rowland A, Sorich MJ.

Cancers (Basel). 2018 Oct 15;10(10). pii: E384. doi: 10.3390/cancers10100384.

17.

Defining significant childhood illness and injury in the Emergency Department: a consensus of UK and Ireland expert opinion.

Lillitos PJ, Lyttle MD, Roland D, Powell CV, Sandell J, Rowland AG, Chapman SM, Maconochie IK; PERUKI and GAPRUKI.

Emerg Med J. 2018 Nov;35(11):685-690. doi: 10.1136/emermed-2018-207802. Epub 2018 Oct 3.

18.

Data sharing from pharmaceutical industry sponsored clinical studies: audit of data availability.

Hopkins AM, Rowland A, Sorich MJ.

BMC Med. 2018 Sep 28;16(1):165. doi: 10.1186/s12916-018-1154-z.

19.
20.

Cubital tunnel syndrome: Anatomy, clinical presentation, and management.

Andrews K, Rowland A, Pranjal A, Ebraheim N.

J Orthop. 2018 Aug 16;15(3):832-836. doi: 10.1016/j.jor.2018.08.010. eCollection 2018 Sep. Review.

PMID:
30140129
21.

Rowland et al. Respond.

Rowland AS, Gorman SA, Thoma RJ, Annett RA, McGrew CA, Yeo RA, Mayer AR, King JH, Campbell RA.

Am J Public Health. 2018 Jul;108(7):e12-e13. doi: 10.2105/AJPH.2018.304443. No abstract available.

22.

Influence of caudal epidural analgesia on cortisol concentrations and pain-related behavioral responses in mares during and after ovariectomy via colpotomy.

Rowland AL, Glass KG, Grady ST, Cummings KJ, Hinrichs K, Watts AE.

Vet Surg. 2018 Jul;47(5):715-721. doi: 10.1111/vsu.12908. Epub 2018 May 18.

PMID:
29774961
23.

Physiologically Based Pharmacokinetic Modeling to Identify Physiological and Molecular Characteristics Driving Variability in Drug Exposure.

Rowland A, van Dyk M, Hopkins AM, Mounzer R, Polasek TM, Rostami-Hodjegan A, Sorich MJ.

Clin Pharmacol Ther. 2018 Dec;104(6):1219-1228. doi: 10.1002/cpt.1076. Epub 2018 Apr 19.

PMID:
29574693
24.

Assessment of inter-racial variability in CYP3A4 activity and inducibility among healthy adult males of Caucasian and South Asian ancestries.

van Dyk M, Marshall JC, Sorich MJ, Wood LS, Rowland A.

Eur J Clin Pharmacol. 2018 Jul;74(7):913-920. doi: 10.1007/s00228-018-2450-4. Epub 2018 Mar 23.

PMID:
29572563
25.

Food safety evaluation for R-proteins introduced by biotechnology: A case study of VNT1 in late blight protected potatoes.

Habig JW, Rowland A, Pence MG, Zhong CX.

Regul Toxicol Pharmacol. 2018 Jun;95:66-74. doi: 10.1016/j.yrtph.2018.03.008. Epub 2018 Mar 9. Review.

PMID:
29530614
26.

Predictors of anti-VEGF drug-induced hypertension using different hypertension criteria: a secondary analysis of the COMPARZ study.

Mangoni AA, Kichenadasse G, Rowland A, Sorich MJ.

Ther Adv Med Oncol. 2018 Feb 5;10:1758834018755090. doi: 10.1177/1758834018755090. eCollection 2018.

27.

Balancing Public Protection with Fairness to Doctors.

Rowland A.

Med Leg J. 2018 Jun;86(2):72-80. doi: 10.1177/0025817217752876. Epub 2018 Jan 8. No abstract available.

PMID:
29308972
28.

Prediction of olanzapine exposure in individual patients using physiologically based pharmacokinetic modelling and simulation.

Polasek TM, Tucker GT, Sorich MJ, Wiese MD, Mohan T, Rostami-Hodjegan A, Korprasertthaworn P, Perera V, Rowland A.

Br J Clin Pharmacol. 2018 Mar;84(3):462-476. doi: 10.1111/bcp.13480. Epub 2018 Jan 11.

29.

Evaluation of modafinil as a perpetrator of metabolic drug-drug interactions using a model informed cocktail reaction phenotyping trial protocol.

Rowland A, van Dyk M, Warncken D, Mangoni AA, Sorich MJ, Rowland A.

Br J Clin Pharmacol. 2018 Mar;84(3):501-509. doi: 10.1111/bcp.13478. Epub 2018 Jan 10.

30.

Risk of Concussion During Sports Versus Physical Education Among New Mexico Middle and High School Students.

Campbell RA, Gorman SA, Thoma RJ, Annett RD, McGrew CA, Yeo RA, Mayer AR, King JH, Rowland AS.

Am J Public Health. 2018 Jan;108(1):93-95. doi: 10.2105/AJPH.2017.304107. Epub 2017 Nov 21.

31.

Response to in vitro and physiologically-based pharmacokinetic assessment of the drug-drug interaction potential of canagliflozin.

Miners JO, Pattanawongsa A, Rowland A.

Br J Clin Pharmacol. 2018 Feb;84(2):392-393. doi: 10.1111/bcp.13443. Epub 2017 Nov 3. No abstract available.

32.

Opposing effects of rheumatoid arthritis and low dose prednisolone on arginine metabolomics.

Radhakutty A, Mangelsdorf BL, Drake SM, Rowland A, Smith MD, Mangoni AA, Thompson CH, Burt MG.

Atherosclerosis. 2017 Nov;266:190-195. doi: 10.1016/j.atherosclerosis.2017.10.004. Epub 2017 Oct 6.

PMID:
29035782
33.

Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers.

Hopkins AM, Rowland A, Kichenadasse G, Wiese MD, Gurney H, McKinnon RA, Karapetis CS, Sorich MJ.

Br J Cancer. 2017 Sep 26;117(7):913-920. doi: 10.1038/bjc.2017.274. Epub 2017 Aug 24. Review.

34.

Attention-Deficit/Hyperactivity Disorder (ADHD): Interaction between socioeconomic status and parental history of ADHD determines prevalence.

Rowland AS, Skipper BJ, Rabiner DL, Qeadan F, Campbell RA, Naftel AJ, Umbach DM.

J Child Psychol Psychiatry. 2018 Mar;59(3):213-222. doi: 10.1111/jcpp.12775. Epub 2017 Aug 12.

35.

Amiodarone-induced thyroid dysfunction and a perturbed N-desethyl-amiodarone to amiodarone ratio: could a drug-induced toxicity be regulating exposure to the offending agent?

Rowland A, Rowland A, Sorich MJ, Mangoni AA.

Eur J Clin Pharmacol. 2017 Aug;73(8):1051-1052. doi: 10.1007/s00228-017-2261-z. Epub 2017 May 3. No abstract available.

PMID:
28470396
36.

Monodentate phosphine substitution in [Pd(κ3-dppf)(PR3)][BF4]2 (dppf = 1,1'-bis(diphenylphosphino)ferrocene) compounds.

Cabrera KD, Rowland AT, Szarko JM, Diaconescu PL, Bezpalko MW, Kassel WS, Nataro C.

Dalton Trans. 2017 May 2;46(17):5702-5710. doi: 10.1039/c6dt04921d.

PMID:
28266666
37.

The Routine Clinical use of Pharmacogenetic Tests: What it Will Require?

Dias MM, Sorich MJ, Rowland A, Wiese MD, McKinnon RA.

Pharm Res. 2017 Aug;34(8):1544-1550. doi: 10.1007/s11095-017-2128-0. Epub 2017 Feb 24. Review.

PMID:
28236061
38.

Central Myxoma / Myxofibroma of the Jaws: A Clinico-Epidemiologic Review.

Rowland A, Benjamin F, Athanasius-Chukwudi O, Uchenna-Kevin O, Modupeola-Omotara S.

Iran J Otorhinolaryngol. 2017 Jan;29(90):35-42.

39.

Targeted pharmacotherapy after somatic cancer mutation screening.

Polasek TM, Ambler K, Scott HS, Sorich MJ, Kaub PA, Rowland A, Wiese MD, Kichenadasse G.

Version 2. F1000Res. 2016 Jun 30 [revised 2016 Jan 1];5:1551. doi: 10.12688/f1000research.9040.2. eCollection 2016.

40.

Optimized Cocktail Phenotyping Study Protocol Using Physiological Based Pharmacokinetic Modeling and In silico Assessment of Metabolic Drug-Drug Interactions Involving Modafinil.

Rowland A, Mangoni AA, Hopkins A, Sorich MJ, Rowland A.

Front Pharmacol. 2016 Dec 27;7:517. doi: 10.3389/fphar.2016.00517. eCollection 2016.

41.

Inhibition of human UDP-glucuronosyltransferase enzymes by lapatinib, pazopanib, regorafenib and sorafenib: Implications for hyperbilirubinemia.

Miners JO, Chau N, Rowland A, Burns K, McKinnon RA, Mackenzie PI, Tucker GT, Knights KM, Kichenadasse G.

Biochem Pharmacol. 2017 Apr 1;129:85-95. doi: 10.1016/j.bcp.2017.01.002. Epub 2017 Jan 6.

PMID:
28065859
42.

Safety Study of Salmeterol in Asthma in Adults.

Wilsdon T, Kichenadasse G, Rowland A.

N Engl J Med. 2016 Sep 15;375(11):1096-7. doi: 10.1056/NEJMc1608323. No abstract available.

PMID:
27626532
43.

Haemodynamic effects of parenteral vs. enteral paracetamol in critically ill patients: a randomised controlled trial.

Kelly SJ, Moran JL, Williams PJ, Burns K, Rowland A, Miners JO, Peake SL.

Anaesthesia. 2016 Oct;71(10):1153-62. doi: 10.1111/anae.13562.

44.

Kinase inhibitor pharmacokinetics: comprehensive summary and roadmap for addressing inter-individual variability in exposure.

Rowland A, van Dyk M, Mangoni AA, Miners JO, McKinnon RA, Wiese MD, Rowland A, Kichenadasse G, Gurney H, Sorich MJ.

Expert Opin Drug Metab Toxicol. 2017 Jan;13(1):31-49. Epub 2016 Sep 1. Review.

PMID:
27561659
45.

A novel approach for the simultaneous quantification of 18 small molecule kinase inhibitors in human plasma: A platform for optimised KI dosing.

van Dyk M, Miners JO, Kichenadasse G, McKinnon RA, Rowland A.

J Chromatogr B Analyt Technol Biomed Life Sci. 2016 Oct 15;1033-1034:17-26. doi: 10.1016/j.jchromb.2016.07.046. Epub 2016 Jul 26.

PMID:
27521531
46.

GMC review of fitness to practise procedures is complete.

Rowland A.

BMJ. 2016 Jul 6;354:i3654. doi: 10.1136/bmj.i3654. No abstract available.

PMID:
27384323
47.

Failure to evaluate introduction of female genital mutilation mandatory reporting.

Gerry F, Rowland A, Fowles S, Smith S, Hodes D, Creighton S.

Arch Dis Child. 2016 Aug;101(8):778-9. doi: 10.1136/archdischild-2016-311000. Epub 2016 Jun 8. No abstract available.

PMID:
27281454
48.

Risk factors of proteinuria in renal cell carcinoma patients treated with VEGF inhibitors: a secondary analysis of pooled clinical trial data.

Sorich MJ, Rowland A, Kichenadasse G, Woodman RJ, Mangoni AA.

Br J Cancer. 2016 Jun 14;114(12):1313-7. doi: 10.1038/bjc.2016.147. Epub 2016 May 26.

49.

Diagnostic accuracy of PAT-POPS and ManChEWS for admissions of children from the emergency department.

Cotterill S, Rowland AG, Kelly J, Lees H, Kamara M.

Emerg Med J. 2016 Nov;33(11):756-762. doi: 10.1136/emermed-2015-204647. Epub 2016 Apr 11.

50.

Does Digital Ad Exposure Influence Information-Seeking Behavior Online? Evidence From the 2012 Tips From Former Smokers National Tobacco Prevention Campaign.

Kim A, Hansen H, Duke J, Davis K, Alexander R, Rowland A, Mitchko J.

J Med Internet Res. 2016 Mar 16;18(3):e64. doi: 10.2196/jmir.4299.

Supplemental Content

Loading ...
Support Center